Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Ltd

₹ 1,058 3.13%
18 Apr - close price
About

Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.

Key Points

Leading Ayurveda Company
Jeena Sikho Lifecare is a developing healthcare product & services provider in India. The company has a portfolio of a wide range of Ayurvedic products. The company also conducts various health checkup camps, and yoga sessions free of cost to make people aware of their health problems. [1]

  • Market Cap 2,631 Cr.
  • Current Price 1,058
  • High / Low 1,099 / 160
  • Stock P/E 79.4
  • Book Value 50.5
  • Dividend Yield 0.10 %
  • ROCE 52.4 %
  • ROE 40.8 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Promoter holding has increased by 1.71% over last quarter.

Cons

  • Stock is trading at 21.0 times its book value
  • Debtor days have increased from 30.9 to 39.4 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Sep 2022 Mar 2023
75 87 118
66 71 88
Operating Profit 9 16 30
OPM % 12% 18% 25%
0 1 2
Interest 1 1 0
Depreciation 2 1 2
Profit before tax 7 15 29
Tax % 26% 28% 23%
5 11 23
EPS in Rs 2.76 4.45 9.12
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023
147 205
128 159
Operating Profit 18 46
OPM % 12% 22%
1 3
Interest 1 1
Depreciation 3 3
Profit before tax 15 44
Tax % 26% 24%
11 34
EPS in Rs 6.17 13.57
Dividend Payout % 0% 8%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 40%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 212%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 529%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 41%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023
Equity Capital 10 14
Reserves 26 112
7 1
18 24
Total Liabilities 62 151
29 60
CWIP 5 1
Investments 0 5
28 86
Total Assets 62 151

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023
16 15
-18 -33
-5 48
Net Cash Flow -7 29

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023
Debtor Days 23 39
Inventory Days 149 85
Days Payable 109 126
Cash Conversion Cycle 62 -1
Working Capital Days 4 29
ROCE % 52%

Shareholding Pattern

Numbers in percentages

5 Recently
Apr 2022Sep 2022Mar 2023Sep 2023Nov 2023
65.89% 65.89% 66.20% 67.91% 67.91%
0.00% 0.00% 0.00% 2.00% 1.79%
0.00% 0.00% 0.00% 0.04% 0.00%
34.11% 34.11% 33.80% 30.05% 30.30%
No. of Shareholders 1,9518346638151,107

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents